Coya Therapeutics

(NASDAQ) COYA

Current Price$5.89

Market Cap$137.22M

Since IPO (2022)+33%

5 YearN/A

1 Year+2%

1 Month+21%

Coya Therapeutics Financials at a Glance

Market Cap

$137.22M

Revenue (TTM)

$7.94M

Net Income (TTM)

-$21.13M

EPS (TTM)

-$1.08

P/E Ratio

-5.41

Dividend

$0.00

Beta (Volatility)

1.23 (Average)

Dividend

$0.00

Beta (Volatility)

1.23 (Average)

Price

$5.89

Volume

7,151

Open

$6.03

Price

$5.89

Volume

7,151

Open

$6.03

Previous Close

$5.89

Daily Range

$5.87 - $6.19

52-Week Range

$3.71 - $7.75

Estimated Earnings Date

Aug 11, 2026

Dividend

$0.00

Beta (Volatility)

1.23 (Average)

Price

$5.89

Volume

7,151

Open

$6.03

Previous Close

$5.89

Daily Range

$5.87 - $6.19

52-Week Range

$3.71 - $7.75

Estimated Earnings Date

Aug 11, 2026

COYA News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Coya Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Arun Swaminathan, PhD

Website

www.coyatherapeutics.com

Headquarters

Houston, TX 77057, US

COYA Financials

Key Financial Metrics (TTM)

Gross Margin

99.79%

Operating Margin

-277.02%

Net Income Margin

-266.11%

Return on Equity

-57.26%

Return on Capital

-47.10%

Return on Assets

-39.66%

Earnings Yield

-18.48%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$137.22M

Shares Outstanding

23.46M

Volume

7.15K

Avg. Volume

172.09K

Financials (TTM)

Gross Profit

$7.92M

Operating Income

-$21.99M

EBITDA

-$21.10M

Operating Cash Flow

-$14.12M

Capital Expenditure

-$3.00

Free Cash Flow

-$14.12M

Cash & ST Invst.

$50.72M

Total Debt

$0.00

Coya Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$251.15K

-2.6%

Gross Profit

$248.34K

+105.0%

Gross Margin

98.88%

N/A

Market Cap

$137.22M

N/A

Market Cap/Employee

$17.15M

N/A

Employees

N/A

Net Income

-$7.21M

+1.4%

EBITDA

-$7.20M

+1.3%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$50.72M

+42.8%

Total Debt

$0.00

N/A

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-39.66%

N/A

Return on Invested Capital

-44.23%

N/A

Free Cash Flow

-$6.21M

-119.5%

Operating Cash Flow

-$6.21M

-119.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ORMPOramed Pharmaceuticals Inc.

ORMPOramed Pharmaceuticals Inc.$4.81+3.66%

PLRXPliant Therapeutics, Inc.

PLRXPliant Therapeutics, Inc.$1.14-0.87%

CLNNClene Inc.

CLNNClene Inc.$6.16-2.84%

CNTXContext Therapeutics Inc.

CNTXContext Therapeutics Inc.$0.55-4.02%

WHWKWhitehawk Therapeutics Inc

WHWKWhitehawk Therapeutics Inc$4.58+3.85%

MGNXMacroGenics, Inc.

MGNXMacroGenics, Inc.$4.62-4.94%

STTKShattuck Labs, Inc.

STTKShattuck Labs, Inc.$6.94+1.31%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$18.07+0.01%

TAT&T

TAT&T$20.70-0.05%

ONDSOndas

ONDSOndas$8.24+0.03%

SOFISoFi Technologies

SOFISoFi Technologies$17.93-0.01%

NKENike

NKENike$41.05-0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$14.16+0.04%

PATHUiPath

PATHUiPath$10.87+0.02%

Questions About COYA

What is the current price of Coya Therapeutics?

Coya Therapeutics is trading at $5.89 per share.

What is the 52-week range for Coya Therapeutics?

Over the past 52 weeks, Coya Therapeutics has traded between $3.71 and $7.75.

How much debt does Coya Therapeutics have?

As of the most recent reporting period, Coya Therapeutics reported total debt of $0.00.

How much cash does Coya Therapeutics have on hand?

Coya Therapeutics reported $50.72M in cash and cash equivalents in its most recent financial results.

What is Coya Therapeutics’s dividend yield?

Coya Therapeutics does not currently have a dividend yield.

Coya Therapeutics

Coya Therapeutics Financials at a Glance

COYA News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Coya Therapeutics

COYA Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Coya Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About COYA

What is the current price of Coya Therapeutics?

What is the 52-week range for Coya Therapeutics?

How much debt does Coya Therapeutics have?

How much cash does Coya Therapeutics have on hand?

What is Coya Therapeutics’s dividend yield?

Premium Investing Services